TiumBio cuts 2023 stock option grant to 124,000 shares after employee departures

TiumBio corrected its March 29, 2023 stock option grant disclosure, reducing recipients to 13 from 14 and granted shares to 124,000 from 127,000; total options outstanding after the grant were revised to 1,041,988 from 1,017,488. Terms unchanged: exercise price KRW 9,810; exercise window March 29, 2025 to March 28, 2030.